Antibiotic resistance testing of the total implant-associated micro-flora and its pure isolates

European Journal of Medical Research

Volumn 12, Issue 3, 2007, Pages 120-128

  Karbach, Julia ^a   Callaway, A ^a   Willershausen, B ^a   Wagner, W ^a   Geibel, M A ^b   Al Nawas, B ^a  

^a JOHANNES GUTENBERG UNIVERSITY   (Germany)

^b UNIVERSITY OF ULM   (Germany)

Author keywords

Antibiotic resistance; Implant associated micro flora; Mixed cultures; Pure isolates

Indexed keywords

AMPICILLIN; ANTIBIOTIC AGENT; AZITHROMYCIN; MOXIFLOXACIN; PENICILLIN G; SULTAMICILLIN;

ANAEROBIC CELL CULTURE; ANTIBIOTIC RESISTANCE; ANTIBIOTIC SENSITIVITY; ARTICLE; BACTERIAL GROWTH; BACTERIAL STRAIN; BACTERIUM COLONY; BACTERIUM IDENTIFICATION; BACTERIUM ISOLATE; BACTERIUM ISOLATION; CLINICAL ARTICLE; CONTROLLED STUDY; FEMALE; FUNGAL STRAIN; FUNGUS IDENTIFICATION; FUNGUS ISOLATION; GRAM POSITIVE COCCI; HUMAN; MALE; MICROFLORA; MICROMONAS MICROS; MIXED CELL CULTURE; MOUTH FLORA; NONHUMAN; SMOKING HABIT; STAPHYLOCOCCUS; TOOTH IMPLANTATION; YEAST;

AMPICILLIN; ANTI-BACTERIAL AGENTS; AZA COMPOUNDS; AZITHROMYCIN; BACTERIA, ANAEROBIC; DENTAL IMPLANTS; DENTAL PLAQUE; DOSE-RESPONSE RELATIONSHIP, DRUG; DRUG COMBINATIONS; DRUG RESISTANCE, BACTERIAL; FEMALE; GRAM-NEGATIVE BACTERIA; GRAM-POSITIVE COCCI; GRAM-POSITIVE RODS; HUMANS; MALE; MICROBIAL SENSITIVITY TESTS; PENICILLIN G; QUINOLINES; SULBACTAM;

EID: 34147103473     PISSN: 09492321     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (52)

1. Aas JA, Paster BJ, Stokes LN, Olsen I, Dewhirst FE. Defining the normal bacterial flora of the oral cavity. J Clin Microbiol. 2005; 43: 5721-32.
2. Akimoto Y, Shibutani J, Nishimura H, Komiya M, Shibata T, Tadokoro H, Kaneko K, Fujii A, Tamura T. Ampicillin concentrations in human serum and periodontal membrane following a single oral administration of bacampicillin. Gen Pharmacol. 1986; 17: 227-9.
3. Alcoforado GA, Rams TE, Feik D, Slots J. Microbial aspects of falling osseointegrated dental implants in humans. J Parodontol. 1991; 10: 11-8.
4. Almstahl A, Wirkstrom M, Stenberg I, Jakobsson A, Fagerberg-Mohlin B. Oral microbiota associated with hyposalivation of different origins. Oral Microbiol Immunol. 2003; 18: 1-8.
5. Augthun M, Conrads G. Microbial findings of deep periimplant bone defects. Int J Oral Maxillofac Implants. 1997; 12: 106-12.
6. Berglundh T, Lindhe J, Marinello C, Ericsson I, Liljenberg B. Soft tissue reaction to de novo plaque formation on implants and teeth. An experimental study in the dog. Clin Oral Implants Res. 1992; 3: 1-8.
7. Betriu C, Rodriguez-Avial I, Gomez M, Culebras E, Picazo JJ. Changing patterns of fluoroquinolone resistance among Bacteroides fragilis group organisms over a 6-year period (1997-2002). Diagn Microbiol Infect Dis. 2005; 53: 221-3.
8. Blandizzi C, Malizia T, Lupetti A, Pesce D, Gabriele M, Giuca MR, Campa M, Del Tacca M, Senesi S. Periodontal tissue disposition of azithromycin in patients affected by chronic inflammatory periodontal diseases. J Periodontol. 1999; 70: 960-6.
9. Brook I. Antibiotic resistance of oral anaerobic bacteria and their effect on the management of upper respiratory tract and head and neck infections. Semin Respir Infect. 2002; 17: 195-203.
10. Brook I. Microbiology and management of intra-abdominal infections in children. Pediatr Int. 2003; 45: 123-9.
11. Cebrian L, Rodriguez JC, Escribano 1, Royo G. Characterization of Salmonella spp. mutants with reduced fluoroquinolone susceptibility: importance of efflux pump mechanisms. Chemotherapy. 2005; 51: 40-3.
12. DiPiro JT. Considerations for therapy of mixed infections: focus on intraabdominal infection. Pharmacotherapy. 1995; 15: 13S-21S.
13. Fosse T, Madinier I, Hitzig C, Charbit Y. Prevalence of beta-lactamase-producing strains among 149 anaerobic gram-negative rods isolated from periodontal pockets. Oral Microbiol Immunol. 1999; 14: 352-7.
14. Goldstein EJ. Intra-abdominal anaerobic infections: bacteriology and therapeutic potential of newer antimicrobial carbapenem, fluoroquinolone, and desfluoroquinolone therapeutic agents. Clin Infect Dis. 2002; 35: S106-S111.
15. Jain R, Danziger LH. The macrolide antibiotics: a pharmacokinetic and pharmocodynamic overview. Curr Pharm Des. 2004; 10: 3045-53.
16. Kampougeris G, Antoniadou A, Kavouklis E, Chryssouli Z, Giamarellou H. Penetration of moxifloxacin into the human aqueous humour after oral administration. Br J Ophthalmol. 2005; 89: 628-31.
17. Kara D, Luppens SB, Cate JM. Differences between single- and dual-species biofilms of Streptococcus mutans and Veillonella parvula in growth, acidogenicity and susceptibility to chlorhexidine. Eur J Oral Sci. 2006; 114: 58-63.
18. Larsen T. Susceptibility of Porphyromonas gingivalis in biofilms to amoxicillin, doxycycline and metronidazole. Oral Microbiol Immunol. 2002; 17: 267-71.
19. Leonhardt A, Renvert S, Dahlen G. Microbial findings at failing implants. Clin Oral Implants Res. 1999; 10: 339-45.
20. Lewis MA, Parkhurst CL, Douglas CW, Martin MV, Absi EG, Bishop PA, Jones SA. Prevalence of penicillin resistant bacteria in acute suppurative oral infection. J Antimicrob Chemother. 1995; 35: 785-91.
21. Luterbacher S, Mayfield L, Bragger U, Lang NP. Diagnostic characteristics of clinical and microbiological tests for monitoring periodontal and peri-implant mucosal tissue conditions during supportive periodontal therapy (SPT). Clin Oral Implants Res. 2000; 11: 521-9.
22. Malizia T, Tejada MR, Ghelardi E, Senesi S, Gabriele M, Giuca MR, Blandizzi C, Danesi R, Campa M, Del Tacca M. Periodontal tissue disposition of azithromycin. J Periodontol 1997; 68: 1206-9.
23. Marsh PD. Dental plaque as a microbial biofilm. Caries Res. 2004; 38: 204-11.
24. Marsh PD. Dental plaque: biological significance of a biofilm and community life-style. J Clin Periodontol. 2005; 32 Suppl 6: 7-15.
25. Marsh PD. Plaque as a biofilm: pharmacological principles of drug delivery and action in the sub- and supragingival environment. Oral Dis. 2003; 9 Suppl 1: 16-22.
26. Molin S. Tolker-Nielsen T. Gene transfer occurs with enhanced efficiency in biofilms and induces enhanced stabilisation of the biofilm structure. Curr Opin Biotechnol. 2003; 14: 255-61.
27. Mombelli A, Lang NP. The diagnosis and treatment of peri-implantitis. Periodontol 2000. 1998; 17: 63-76.
28. Mombelli A, Mericske-Stern R. Microbiological features of stable osseointegrated implants used as abutments for overdentures. Clin Oral Implants Res. 1990; 1: 1-7.
29. Mombelli A, van Oosten MA, Schurch E Jr, Land NP. The microbiota associated with successful or failing osseointegrated titanium implants. Oral Microbiol Immunol. 1987; 2: 145-51.
30. Mombelli A. In vitro models of biological responses to implant microbiological models. Adv Dent Res. 1999; 13: 67-72.
31. Mombelli A. Microbiology and antimicrobial therapy of peri-implantitis. Periodontol 2000. 2002; 28: 177-89.
32. Mombelli A. Microbiology of the dental implant. Adv Dent Res. 1993; 7: 202-6.
33. Mühlemann HR, Son S. Gingival sulcus bleeding- a leading symptom in initial gingivitis. Helv Odontol Acta. 1971; 15: 107-13.
34. Müller HP, Holderrieth S, Burkhardt U, Hoffler U. In vitro antimicrobial susceptibility of oral strains of Actinobacillus actinomycetemcomitans to seven antibiotics. J Clin Periodontol. 2002; 29; 736-42.
35. Nahata MC, Vashi VI, Swanson RN, Messig MA, Chung M. Pharmacokinetics of ampicillin and sulbactam in pediatric patients. Antimicrob Agents Chemother. 1999; 43: 1225-9.
36. Pahkla ER, Koppel T, Saag M, Pahkla R. Metronidazole concentrations in plasma, saliva and periodontal pockets in patients with periodontitis. J Clin Periodontol. 2005; 32: 163-6.
37. Pontoriero R, Tonelli MP, Carnevale G, Mombelli A, Nyman SR, Lang NP. Experimentally enduced peri-implant mucositis. A clinical study in humans. Clin Oral Implants Res. 1994; 5: 254-9.
38. Prabhu RM, Piper KE, Litzow MR, Steckelberg JM, Patel R. Emergence of quinolone resistance among viridans group streptococci isolated from the oropharynx of neutropenic peripheral blood stem cell transplant patients receiving quinolone antimicrobial prophylaxis. Eur J Clin Microbiol Infect Dis. 2005; 24: 832-8.
39. Rams TE, Feik D, Slots J. Staphylococci in human periodontal diseases. Oral Microbiol Immunol. 1990; 5: 29-32.
40. Rams TE, Link CC, Jr. Microbiology of falling dental implants in humans: electron microscopic observations. J Oral Implantol. 1983; 11: 93-100.
41. Salcetti JM, Moriarty JD, Cooper LF, Smith FW, Collins JG, Socransky SS, Offenbacher S. The clinical, microbial, and host response characteristics of the failing implant. Int J Oral Maxillofac Implants. 1997; 12: 32-42.
42. Sanchez-Garces MA, Gay-Escoda C. Periimplantitis. Med Oral Patol Oral Cir Bucal. 2004; 9 Suppl: 69-74.
43. Slots J, Rams TE. Antibiotics in periodontal therapy: advantages and disadvantages. J Clin Periodontol 1990; 17: 479-93.
44. Slots J, Ting M. Systemic antibiotics in the treatment of periodontal disease. Periodontol 2000. 2002; 28:106-76.
45. Slots J. The predominant cultivable microflora of advanced periodontitis. Scand J Dent Res. 1977; 85:114-21.
46. 6Socransky SS, Haffajee AD. Evidence of bacterial etiology: a historical perspective. Periodontol 2000. 1994; 5: 7-25.
47. Tozum TF, Yildirim A, Caglayan F, Dincel A, Bozkurt A. Serum and gingival crevicular fluid levels of ciprofloxacin in patients with periodontitis. J Am Dent Assoc. 2004; 135: 1728-32.
48. Van Winkelhoff AJ, Herrera GD, Winkel EG, Dellemijn-Kippuw N, Vandenbroucke-Grauls CM, Sanz M. Antimicrobial resistance in the subgingival microflora in patients with adult periodontitis. A comparison between. The Netherlands and Spain. J Clin Periodontol. 2000;27:79-86.
49. Van Winkelhoff AJ, Winkel EG, Barendregt D, Dellemijn-Kippuw N, Stijne A, van der Velden U. Beta-Lactamase producing bacteria in adult periodontitis. J Clin Periodontol. 1997; 24: 538-43.
50. Walker CB, Gordon JM, Socransky SS. Antibiotic susceptibility testing of subgingival plaque samples. J Clin Periodontol. 1983; 10: 422-32.
51. Weischer T, von Recklinghausen G, Dermoumi H, Mohr C, Schettler D. Periimplantäre Mikroflora bestrahlter und nicht bestrahlter Tumorpatienten. Zahnärztliche Implantologie. 1996; 12: 164-8.
52. Wilson BA, Salyers AA. Is the evolution of bacterial pathogens an out-of-body experience? Trends Microbiol. 2003; 11: 347-50.